News

  1. Home
  2. News

Our new paper, published in ACS Nano: “Polysaccharide Nanoparticles Can Efficiently Modulate the Immune Response against an HIV Peptide Antigen”

Do you want to learn more details about our research? Just check out the VIDEO where our colleague Tamara Dacoba explains the key aspects of this publication!

With MEFISTO against knee osteoarthrosis

The EU project MEFISTO (‘Meniscal functionalised scaffold to prevent knee Osteoarthritis onset after meniscectomy‘), which has just been launched, aims to take advantage of novel approaches and sets itself the clear goal to successfully counteract the epidemic of post-meniscectomy knee osteoarthritis

María José Alonso, new Editor-in-Chief of the ‘Drug Delivery and Translational Research Journal’

María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC) and current President of the Controlled Release Society (CRS, Inc) is the new Editor-in-Chief of 'Drug Delivery and Translational Research' (DDTR), an Official Journal of the Controlled Release Society published by Springer Nature.

The University of Santiago de Compostela awards the title of Doctor Honoris Causa to Professor Nicholas A. Peppas

The USC joins other ten academic institutions that have recognized with this honor the career of this eminent scientist, Director of the Institute of Biomaterials, Drug Delivery and Regenerative Medicine of the University of Texas at Austin.

María José Alonso, the Spanish woman whose scientific publications have the greatest impact on research

Professor Alonso is number one in the h-index ranking of Spanish female researchers in the area of Health Sciences. The h-index is an indicator of the impact of research publications. Alonso also leads the h-index ranking of male/female Spanish researchers in the specific area of Pharmacology and Pharmacy.

Our latest paper, published in Journal of Drug Targeting: “Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system”

The objective of this work was to evaluate the influence of particle size (≈100 versus 200 nm) and surface composition of polymeric nanocapsules (chitosan, polyarginine and carboxymethyl-β-glucan) on their ability to target specific immune cells in the lymphatics.

Get free access to our latest paper: “Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells”

Free access until February 21 to this article, dedicated to Prof. N. Peppas and Prof. R. Langer, published in Journal of Controlled Release

Alonso’s Lab: champion and member of the month of the Oral Drug Delivery Focus Group of the Controlled Release Society

The Oral Delivery Focus Group of the CRS announced Maria Jose Alonso as the Controlled Release Society Oral Delivery Focus Group February Member of the Month and published a ‘Member Spotlight’ profile highlighting her achievements in science.

“A multifunctional drug nanocarrier for efficient anticancer therapy”, article dedicated to Prof. N. Peppas and Prof. R. Langer, published in Journal of Controlled Release

The nanocarrier consisting of functionalized Lyp1-hyaluronic acid nanocapsules accumulated drastically in the tumor tissue (a-37 times higher tumor accumulation than Taxotere®), a fact that was translated into a drastic decrease in tumor growth and metastatic spreading, in an orthotopic lung cancer model.

Alonso’s Lab Mini-Congress 2018

The Alonso’s Lab mini-congress is an annual event aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work.